[go: up one dir, main page]

EE200000309A - Kompositsioonid ja meetodid inimeste spermatosoidide kontsentratsiooni ja/või liikuvuse suurendamiseks - Google Patents

Kompositsioonid ja meetodid inimeste spermatosoidide kontsentratsiooni ja/või liikuvuse suurendamiseks

Info

Publication number
EE200000309A
EE200000309A EEP200000309A EEP200000309A EE200000309A EE 200000309 A EE200000309 A EE 200000309A EE P200000309 A EEP200000309 A EE P200000309A EE P200000309 A EEP200000309 A EE P200000309A EE 200000309 A EE200000309 A EE 200000309A
Authority
EE
Estonia
Prior art keywords
motility
compositions
concentration
increasing
methods
Prior art date
Application number
EEP200000309A
Other languages
English (en)
Inventor
Cavazza Claudio
Original Assignee
Sigma-Tau Healthscience S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26820998&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EE200000309(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US08/980,821 external-priority patent/US5863940A/en
Application filed by Sigma-Tau Healthscience S.P.A. filed Critical Sigma-Tau Healthscience S.P.A.
Publication of EE200000309A publication Critical patent/EE200000309A/et

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gynecology & Obstetrics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pregnancy & Childbirth (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EEP200000309A 1997-12-01 1998-11-18 Kompositsioonid ja meetodid inimeste spermatosoidide kontsentratsiooni ja/või liikuvuse suurendamiseks EE200000309A (et)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/980,821 US5863940A (en) 1997-12-01 1997-12-01 Medicament and therapeutical method for treating idiopathic asthenozoospermia
US09/122,897 US6090848A (en) 1997-12-01 1998-07-28 Compositions and methods for increasing the concentration and/or motility of spermatozoa in humans
PCT/IT1998/000324 WO1999027925A1 (en) 1997-12-01 1998-11-18 Compositions and methods for increasing the concentration and/or motility of spermatozoa in humans

Publications (1)

Publication Number Publication Date
EE200000309A true EE200000309A (et) 2001-08-15

Family

ID=26820998

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200000309A EE200000309A (et) 1997-12-01 1998-11-18 Kompositsioonid ja meetodid inimeste spermatosoidide kontsentratsiooni ja/või liikuvuse suurendamiseks

Country Status (23)

Country Link
US (1) US6090848A (et)
EP (1) EP1039894B1 (et)
JP (1) JP2001524520A (et)
KR (1) KR20010032702A (et)
CN (1) CN1184966C (et)
AT (1) ATE206916T1 (et)
AU (1) AU749754B2 (et)
BR (1) BR9814711A (et)
CA (1) CA2314942C (et)
DE (1) DE69802113T2 (et)
DK (1) DK1039894T3 (et)
EE (1) EE200000309A (et)
ES (1) ES2163896T3 (et)
HK (1) HK1033280A1 (et)
HU (1) HU228989B1 (et)
IL (1) IL136299A0 (et)
IS (1) IS5501A (et)
NO (1) NO20002798L (et)
PL (1) PL192438B1 (et)
PT (1) PT1039894E (et)
SK (1) SK7572000A3 (et)
TR (1) TR200001519T2 (et)
WO (1) WO1999027925A1 (et)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1218001E (pt) * 1999-09-03 2009-03-31 Sigma Tau Ind Farmaceuti L-carnitina ultrafina, métodos de preparação da mesma, composições contendo a mesma, e métodos de utilização da mesma
ITRM20010029A1 (it) * 2001-01-23 2002-07-23 Aldo Fassi Sali metallici di carnitine utili come integratori dietetici/nutrizionali o come farmaci, composizioni che li contengono e procedimenti per
LV12978B (en) * 2001-09-07 2003-05-20 Ivars Kalvins Pharmaceutical composition
KR20040032954A (ko) * 2001-09-12 2004-04-17 어플라이드 리서치 시스템스 에이알에스 홀딩 엔.브이. 과배란 유도에서 ｈＣＧ의 용도
ES2356895T3 (es) * 2001-09-12 2011-04-14 Merck Serono Sa USO DE LA hCG Y LH EN LA HIPERESTIMULACIÓN OVÁRICA CONTROLADA.
ITRM20010621A1 (it) * 2001-10-18 2003-04-18 Aldo Fassi Sali metallici non igroscopici e idrosolubili di alcanoil l-carnitine, integratori dietetici che li contengono e kit dietetici, per contrast
ITRM20020194A1 (it) * 2002-04-09 2003-10-09 Sigma Tau Healthscience Spa Composizione utile per aumentare la concentrazione e la motilita' degli spermatozoi e migliorarne la morfologia nell'uomo.
US7776913B2 (en) 2002-12-13 2010-08-17 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Carnitines for treating or preventing disorders caused by andropause
AT503219B1 (de) 2006-02-03 2008-07-15 Annerl Brigitte Kombinationspräparat auf basis von antioxidanzien zur verbesserung der samenqualität
PT2086642E (pt) * 2006-10-18 2014-09-30 Periness Ltd Dnase para o tratamento de subfertilidade masculina
DE102007053369A1 (de) 2007-11-09 2009-07-02 Alzchem Trostberg Gmbh Verwendung einer eine Kreatin-Komponente enthaltende Zusammensetzung zur Verbesserung der männlichen Fruchtbarkeit
WO2009068278A2 (en) * 2007-11-30 2009-06-04 Bayer Consumer Care Ag A pharmaceutical composition
US20110015154A1 (en) * 2009-07-20 2011-01-20 Kellermann Gottfried H Supporting acetylcholine function
US20110098265A1 (en) * 2009-10-28 2011-04-28 Neuroscience, Inc. Methods for reducing cravings and impulses associated with addictive and compulsive behaviors
BR112016010875B1 (pt) * 2013-12-05 2020-07-14 Alfasigma S.p.A Composição útil para a promoção da fertilidade feminina
CN105695398A (zh) * 2016-04-25 2016-06-22 广西大学 含o-乙酰基-l-肉碱盐酸盐的水牛卵母细胞体外成熟液及培养方法
ES2813573T3 (es) * 2016-07-11 2021-03-24 Laboratoire Des Granions Composición que comprende L-carnitina para el tratamiento de la infertilidad masculina
CN107375346A (zh) * 2017-07-25 2017-11-24 昭远制药(上海)有限公司 提高人类精子浓度和运动性的组合物及其制备方法

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1235153B (it) * 1988-11-15 1992-06-22 Sigma Tau Ind Farmaceuti Uso dell'acetil l-carnitina nel trattamento terapeutico della cataratta e composizioni farmaceutiche utili in tale trattamento
IT1224795B (it) * 1988-12-01 1990-10-24 Sigma Tau Ind Farmaceuti Uso dell'acetil d-carnitina nel trattamento terapeutico del glaucoma e composizioni farmaceutiche utili in tale trattamento
IT1224842B (it) * 1988-12-27 1990-10-24 Sigma Tau Ind Farmaceuti Uso di derivati della l-carnitina nel trattamento terapeutico delle alterazioni degenerative del sistema nervoso
IT1240760B (it) * 1990-02-12 1993-12-17 Sigma Tau Ind Farmaceuti Esteri di acil-l-carnitine con l'acido gamma-idrossibutirrico e composizioni farmaceutiche che li contengono per l'inibizione della degenerazione neuronale e nel trattamento del coma.
IT1240799B (it) * 1990-03-15 1993-12-17 Sigma Tau Ind Farmaceuti Composizioni farmaceutiche contenenti 3-metiltiopropionil l-carnitina ad attivita' sul sistema cardiovascolare.
IT1244636B (it) * 1991-01-04 1994-08-08 Sigma Tau Ind Farmaceuti Uso dell'acetil l-carnitina nel trattamento terapeutico del coma e composizioni farmaceutiche utili in tale trattamento.
IT1248323B (it) * 1991-05-16 1995-01-05 Sigma Tau Ind Farmaceuti Ammidi con amminoacidi naturali di alcanoil l-carnitine quali inibitori della degenerazione neuronale e attivatori dei processi di apprendimento e memorizzazione e per il trattamento del coma e composizioni farmaceutiche comprendenti tali composti
IT1245699B (it) * 1991-05-29 1994-10-14 Sigma Tau Ind Farmaceuti Derivati della l-carnitina quali agenti terapeutici per il trattamento delle miopatie, della degenarazione neuronale e per inibire la proteolisi
IT1249462B (it) * 1991-10-21 1995-02-23 Sigma Tau Ind Farmaceuti Impiego di l-carnitina e acil l-carnitine nel trattamento delle oligoastenospermie idiopatiche.
IT1263004B (it) * 1992-10-08 1996-07-23 Sigma Tau Ind Farmaceuti Impiego della l-carnitina e acil l-carnitine nel trattamento a lungo termine di pazienti diabetici non insulino-dipendenti.
IT1263013B (it) * 1992-10-20 1996-07-23 Avantgarde Spa Esteri della l-carnitina e di alcanoil l-carnitine con l'acido glicolico o suoi esteri e composizioni farmaceutiche contenenti tali per il trattamento di affezioni cutanee.
IT1261688B (it) * 1993-05-28 1996-05-29 Avantgarde Spa Uso di esteri sull'ossidrile della l-carnitina per produrre composizioni farmaceutiche per il trattamento di affezioni cutanee.
IT1261696B (it) * 1993-06-02 1996-05-29 Avantgarde Spa Uso di esteri sull'ossidrile della l-carnitina con acidi aromatici perprodurre composizioni farmaceutiche per il trattamento di affezioni cutanee.
IT1261984B (it) * 1993-06-22 1996-06-11 Avantgarde Spa Uso di esteri della l-carnitina o di acil l- carnitine con idrossiacidi per produrre composizioni farmaceutiche per il trattamento di affezioni cutanee.
IT1272290B (it) * 1994-06-20 1997-06-16 Avantgarde Spa Sale della l-carnitina e composizioni farmaceutiche che lo contengono per il trattamento di affezioni cutanee
IT1274157B (it) * 1994-09-08 1997-07-15 Avantgarde Spa "sale della l-carnitina e composizioni farmaceutiche che lo contengonoper il trattamento di affezioni cutanee"
IT1274156B (it) * 1994-09-08 1997-07-15 Avantgarde Spa "sale della l-carnitina e composizioni farmaceutiche che lo contengonoper il trattamento di affezioni cutanee"
IT1276225B1 (it) * 1995-10-17 1997-10-27 Sigma Tau Ind Farmaceuti Composizioni farmaceutiche contenenti l-carnitina e alcanoil l- carnitine in associazione con resveratrolo o suoi derivati utili per
IT1277953B1 (it) * 1995-12-21 1997-11-12 Sigma Tau Ind Farmaceuti Composizione farmaceutica contenente l-carnitina o una alcanoil l- carnitina e un acido poliinsaturo della serie 3-omega utile per
US5889055A (en) * 1997-04-04 1999-03-30 Howard; James R. L-carnitine and acetyl-L-carnitine combined for prevention and treatment of syndromes related to diseases of energy metabolism
IT1295408B1 (it) * 1997-10-03 1999-05-12 Sigma Tau Ind Farmaceuti Associazione di l-carnitina e alcanoil l-carnitine per il trattamento dell'alcoolismo

Also Published As

Publication number Publication date
DK1039894T3 (da) 2002-02-11
IS5501A (is) 2000-05-19
JP2001524520A (ja) 2001-12-04
US6090848A (en) 2000-07-18
IL136299A0 (en) 2001-05-20
PL192438B1 (pl) 2006-10-31
EP1039894B1 (en) 2001-10-17
HK1033280A1 (en) 2001-08-24
DE69802113D1 (de) 2001-11-22
WO1999027925A1 (en) 1999-06-10
TR200001519T2 (tr) 2000-11-21
PT1039894E (pt) 2002-04-29
BR9814711A (pt) 2000-10-03
CA2314942A1 (en) 1999-06-10
DE69802113T2 (de) 2002-06-06
NO20002798L (no) 2000-06-27
CN1284871A (zh) 2001-02-21
KR20010032702A (ko) 2001-04-25
HUP0004562A3 (en) 2003-05-28
NO20002798D0 (no) 2000-05-31
CN1184966C (zh) 2005-01-19
ATE206916T1 (de) 2001-11-15
EP1039894A1 (en) 2000-10-04
PL342115A1 (en) 2001-05-21
CA2314942C (en) 2009-05-05
ES2163896T3 (es) 2002-02-01
HU228989B1 (en) 2013-07-29
AU749754B2 (en) 2002-07-04
AU1259199A (en) 1999-06-16
SK7572000A3 (en) 2000-11-07
HUP0004562A2 (hu) 2001-05-28

Similar Documents

Publication Publication Date Title
EE200000309A (et) Kompositsioonid ja meetodid inimeste spermatosoidide kontsentratsiooni ja/või liikuvuse suurendamiseks
BR0107749A (pt) Métodos de uso de uma composição de bebida
MXPA05006194A (es) Metodo para utilizar una composicion de bebida.
PT979244E (pt) Derivados de ciclosporina, sua preparacao e composicoes farmaceuticas que os contem
PT948527E (pt) Novos derivados de ciclosporina sua preparacao e composicoes farmaceuticas que os contem
MY123354A (en) 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives
CA2370030A1 (en) Sodium channel blocker compositions and the use thereof
CY1112139T1 (el) Μια φαρμακευτικη συνθεση περιλαμβανουσα κρυσταλλικη ριτοναβιρη μορφη ιι και ενα παρασκευασμα εξ αυτης
IS2789B (is) Lyfjablöndur sem innihalda mónóamínoxídasa B hemla
EA200001010A1 (ru) Применение дексмедетомидина для седативного воздействия в отделении интенсивной терапии
FI973691A0 (fi) Amlodipiinia tai sen suolaa tai felodipiinia ja ACE:n estäjää sisältäviä koostumuksia
UA26403A (uk) Похідhі n-заміщеhого 4-феhіл-4-піперидиhкарбоксаміду та їх фармацевтичhо прийhятhі солі, що проявляють аhестезувальhу та аhальгезувальhу дію, спосіб їх одержаhhя та фармацевтичhа композиція
MX9705916A (es) Terapia de combinacion para infeccion por vih usando el inhibidor de proteasa de vih indinavir y el inhibidor de transcriptasa inversa 3tc, opcionalmente junto con azt, ddi, o ddc.
GB2209281B (en) Pharmaceutical compositions comprising an alpha-2 adrenoceptor antagonist
AU567018B2 (en) Prazosin-pirbuterol combination for bronchoduation
ATE159511T1 (de) Derivate von n,n,n',n'-tetrasubstituierten 1,2- ethylendiamin-verbindungen
CO4910113A1 (es) Composiciones farmaceuticas estabilizadas, a base de quinu- pristina y de dalfopristina y su preparacion
AP9801235A0 (en) Erythromycin derivatives.
GR3034142T3 (en) Composition for the treatment or prevention of herpes
IE840977L (en) Pharmaceutical preparations
BR0113886A (pt) Composição, composição farmacêutica, tratamento de combinação para prevenir ou inibir a geração ou atividade de trombina num paciente, método para inibir ou prevenir a geração ou atividade de trombina num paciente, uso de uma composição ou tratamento de combinação, uso de uma composição, uso e kit
GB9015774D0 (en) Novel treatment